Trials / Completed
CompletedNCT00280371
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD
A 12-week Double-Blind, Parallel-Group, Placebo- and Active- Controlled Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate Inhalation Solution 20 Mcg/0.5 mL Delivered by OMRON MicroAir NE-U22V Nebulizer in the Treatment of Patients With Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 345 (planned)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formoterol Fumarate |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2006-07-01
- Completion
- 2007-05-01
- First posted
- 2006-01-23
- Last updated
- 2010-11-11
Locations
52 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00280371. Inclusion in this directory is not an endorsement.